CPT® Code 83905

Deleted

1. Indications

The procedure associated with CPT® Code 83905 is indicated for the identification of specific genetic mutations that may be relevant to various diseases. This testing is particularly useful in the following scenarios:

• Genetic Testing for Hereditary Conditions This test is performed to identify mutations that may be inherited and could lead to hereditary diseases.
• Oncology It is utilized in cancer diagnostics to detect mutations that may influence treatment decisions and prognostic evaluations.
• Pharmacogenomics The procedure can assist in determining how genetic variations affect an individual's response to certain medications.

2. Procedure

The procedure for CPT® Code 83905 involves several key steps to ensure accurate mutation identification through allele-specific transcription. Each step is critical for the successful execution of the test:

• Sample Collection A biological sample, typically blood or tissue, is collected from the patient. This sample serves as the source of DNA for analysis.
• DNA Extraction The DNA is extracted from the collected sample using standardized laboratory techniques to ensure purity and integrity for testing.
• Allele-Specific Transcription The extracted DNA undergoes allele-specific transcription, where specific segments of the DNA are transcribed to identify the presence of particular alleles associated with mutations.
• Data Analysis The results of the transcription are analyzed to determine the presence or absence of the targeted mutations, providing critical information for diagnosis and treatment.

3. Post-Procedure

After the completion of the procedure associated with CPT® Code 83905, the patient may not require any specific post-procedure care related to the test itself, as it is a laboratory-based analysis. However, it is essential for healthcare providers to discuss the results with the patient once they are available. This discussion may include the implications of the findings, potential next steps in management or treatment, and any necessary follow-up testing or evaluations based on the identified mutations. Additionally, patients may be advised to monitor for any symptoms related to the conditions being tested, as well as to maintain regular communication with their healthcare provider regarding their health status.